Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Minden

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Blood Cells|June 15, 1979
Acute myeloblastic leukemia considered as a clonal hemopathyE A McCulloch, A F Howatson, R N Buick, et al.
Leukemia|February 13, 2013
Gads (Grb2-related adaptor downstream of Shc) is required for BCR-ABL-mediated lymphoid leukemiaL C Gillis, D M Berry, M D Minden, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1981
Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNAP P Major, E M Egan, G P Beardsley, et al.
European Journal of Immunology|July 1, 1988
Structure and rearrangement of the T cell receptor J alpha locus in T cells and leukemic T cell linesE Champagne, U Sagman, A Biondi, et al.
Leukemia|May 20, 2005
The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cellsM R Trus, L Yang, F Suarez Saiz, et al.
Leukemia|January 1, 1997
A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemiaD W Hedley, S X Xie, M D Minden, et al.
Leukemia|August 23, 2001
Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cellsZ Xia, M M Tan, W W Wong, et al.
Bone Marrow Transplantation|August 1, 1994
Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemiaW M Xu, X H Piao, L Addy, et al.
Hematology (Amsterdam, Netherlands)|May 15, 2003
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemiasV Gupta, S Kamel-Reid, M D Minden, et al.
Leukemia & Lymphoma|June 28, 2001
Lovastatin induces a pronounced differentiation response in acute myeloid leukemiasJ Dimitroulakos, S Thai, G H Wasfy, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Blood Cells|June 15, 1979
Acute myeloblastic leukemia considered as a clonal hemopathyE A McCulloch, A F Howatson, R N Buick, et al.
Leukemia|February 13, 2013
Gads (Grb2-related adaptor downstream of Shc) is required for BCR-ABL-mediated lymphoid leukemiaL C Gillis, D M Berry, M D Minden, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1981
Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNAP P Major, E M Egan, G P Beardsley, et al.
European Journal of Immunology|July 1, 1988
Structure and rearrangement of the T cell receptor J alpha locus in T cells and leukemic T cell linesE Champagne, U Sagman, A Biondi, et al.
Leukemia|May 20, 2005
The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cellsM R Trus, L Yang, F Suarez Saiz, et al.
Leukemia|January 1, 1997
A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemiaD W Hedley, S X Xie, M D Minden, et al.
Leukemia|August 23, 2001
Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cellsZ Xia, M M Tan, W W Wong, et al.
Bone Marrow Transplantation|August 1, 1994
Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemiaW M Xu, X H Piao, L Addy, et al.
Hematology (Amsterdam, Netherlands)|May 15, 2003
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemiasV Gupta, S Kamel-Reid, M D Minden, et al.
Leukemia & Lymphoma|June 28, 2001
Lovastatin induces a pronounced differentiation response in acute myeloid leukemiasJ Dimitroulakos, S Thai, G H Wasfy, et al.
Pageof 15